CorVel Corp. 10-Q Summary: Quarter Ended September 30, 2001
Business Context and Reporting Period
This Form 10-Q covers the second quarter of CorVel Corp.'s fiscal year ending March 31, 2002, specifically the period ended September 30, 2001. CorVel provides managed care services, primarily in the workers' compensation sector, including bill review and provider network management. The company reported approximately 11,030,000 shares of common stock outstanding as of September 30, 2001, adjusted for a 3-for-2 stock split executed in August 2001.
Key Financial Metrics
| Metric | Three Months Ended Sept 30, 2001 | Six Months Ended Sept 30, 2001 |
|---|---|---|
| Revenues | $58.4 million | $116.4 million |
| Net Income | $3.6 million | $7.2 million |
| Gross Margin | 17.9% | 17.9% |
| Operating Margin | 10.0% | 10.0% |
| Net Cash from Operations | N/A (Quarterly not provided) | $9.9 million |
| Cash and Equivalents | $8.6 million (as of Sept 30, 2001) | $8.6 million |
| Debt | $0 | $0 |
| Working Capital | $35.7 million | $35.7 million |
Earnings Per Share (Diluted): $0.32 for the quarter; $0.63 for the six-month period.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 13% year-over-year for the quarter ($6.8 million increase) and 14% for the six-month period ($14.2 million increase).
- Driver of Growth: The increase is primarily attributed to a 30% rise in provider program revenues (bill review and PPO), driven by higher volumes of bills reviewed.
- Cost Structure: Cost of revenues increased slightly as a percentage of revenue, from 81.9% to 82.1% for the quarter and from 81.7% to 82.1% for the six months.
- Cash Flow: Net cash provided by operating activities for the six months ended September 30, 2001, was $9.9 million, a decrease from $12.3 million in the prior year period, largely due to changes in accrued liabilities and accounts receivable.
- Capital Allocation: The company continued to purchase treasury stock, using $7.3 million in cash for this purpose during the six-month period.
Outlook, Risks, and Management Commentary
Liquidity: Management states that the current cash balance of $8.6 million, combined with anticipated internally generated funds, is sufficient to meet cash requirements for the next twelve months. The company has no interest-bearing debt.
Accounting Changes: The company is evaluating the impact of new FASB statements (SFAS 141, 142, 143, and 144) regarding business combinations, goodwill, and asset retirement obligations. Adoption of SFAS 142 is expected in the first quarter of fiscal 2003.
Risk Factors:
- Regulation: Evolving state laws regarding medical review services and managed care networks could increase operational costs or limit market access.
- Competition: Increased competition from HMOs, PPOs, and insurers, particularly as legislation allows health plans to cover workers' compensation claims.
- Market Dynamics: Declines in workers' compensation claim volumes and costs in certain states could adversely affect demand for services.
- Legal Liability: Potential litigation regarding medical treatment recommendations, though the company maintains professional liability insurance.
Investor Verification Checklist
- Verify the sustainability of the 30% growth in provider program revenues and whether it is driven by volume or pricing.
- Monitor the impact of new state regulations on licensing and medical review standards on operating costs.
- Assess the company's ability to maintain gross margins as cost of revenues rises slightly relative to revenue growth.
- Review the company's strategy for entering the group health market, where competition is more mature and intense.
- Confirm the adequacy of professional liability insurance coverage given the nature of medical utilization management services.